ArticleBMC veterinary research2026
Epidemiological and genetic variation analysis of emerging porcine circovirus type 3 in Henan Province, 2023-2024.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundPorcine circovirus type 3 (PCV3) is an emerging pathogen with high genetic variability, posing a continuous challenge to swine health and disease control. Ongoing viral evolution highlights the need for molecular surveillance to monitor circulating PCV3 strains.
resultsFrom 2023 to 2024, 257 blood and tissue samples from pigs with reproductive and respiratory disorders were collected in Henan Province, China. PCV3 was detected in 21.79% (56/257) of samples by quantitative real-time PCR (qPCR). Genetic characterization of 15 new PCV3 strains showed 98.95-99.95% nucleotide (nt) identity among themselves and 98.70-99.85% identity with global reference strains. Phylogenetic analysis of the ORF2 genes identified PCV3a-1, PCV3a-2, PCV3a-IM, PCV3b, and PCV3c subtypes, with PCV3b predominating. Notably, a genetically divergent strain, HN240609, clustered within the PCV3c subgroup. Additionally, multiple unique amino acid (aa) mutations were observed in the predicted T-cell and B-cell epitope regions of the capsid (Cap) protein (R10K, A35V, T102A, T102S, F104Y, T170A, and V180I).
conclusionsGenetically diverse PCV3 strains are co-circulating in Henan Province, and mutations in antigenic regions of the Cap protein may facilitate immune evasion. Continuous molecular surveillance is therefore essential for effective PCV3 prevention and control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.